Adjuvant (adj) bevacizumab (B) plus dose-dense (dd) doxorubicin/cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel (nab-p) in early stage breast cancer (BC) patients (pts): Cardiac safety Meeting Abstract


Authors: Dickler, M. N.; Traina, T.; Panageas, K.; Steingart, R.; Dang, C.; Fornier, M.; Sugarman, S.; Norton, L.; Hudis, C.; Rugo, H.
Abstract Title: Adjuvant (adj) bevacizumab (B) plus dose-dense (dd) doxorubicin/cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel (nab-p) in early stage breast cancer (BC) patients (pts): Cardiac safety
Meeting Title: 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 25
Issue: 18 Suppl.
Meeting Dates: 2007 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2007-06-20
Start Page: 19s
Language: English
ACCESSION: WOS:000455043700092
PROVIDER: wos
DOI: 10.1200/jco.2007.25.18_suppl.567
Notes: Meeting Abstract: 567 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Clifford Hudis
    905 Hudis
  2. Larry Norton
    758 Norton
  3. Chau Dang
    271 Dang
  4. Maura N Dickler
    262 Dickler
  5. Richard M Steingart
    174 Steingart
  6. Monica Nancy Fornier
    158 Fornier
  7. Tiffany A Traina
    250 Traina
  8. Katherine S Panageas
    512 Panageas